Enlibrium gets $15M to use metformin analogs for cancer
Enlibrium's technology, licensed out of UCLA, will use diabetes drug metformin to shut down energy production in cancer cells - providing a potentially new frontline treatment for the disease.
Elcelyx: Taking the GI, kidney distress out of diabetes drug metformin
A next-gen form of ubiquitous diabetes drug metformin could have some serious impact on the type 2 diabetes market - as evidenced in some promising Phase 2 data from San Diego startup Elcelyx.
The Hidden Administrative Tasks Draining Small Practices
Small practices play a critical role in healthcare delivery, but they cannot continue to absorb ever-increasing administrative demands without consequences.
Colorado startup’s microbiome-modulating drug could improve metformin tolerability
Diabetes drug metformin may be as effective as it’s ubiquitous, but it’s known to throws the stomach’s balance out of whack. Half the patients experience diarrhea and a quarter vomiting, so patients often scale back on metformin – or stop using it entirely. Also, microbiome imbalances are consistently being linked now to obesity. Colorado startup MicroBiome Therapeutics is […]